Pharmaceutical Financial Modeling Made Easy
Model, analyze, and present the financial impacts and viability of any drug, strategic objective, or financial scenario on your pharmaceutical or bio-technology company. With Synario, a comprehensive look into your pharmaceutical’s financial future is within reach.
Model Any Drug or Product Lifecycle
Completely customizable to your specific needs, Synario's modeling platform can project even the most difficult financial modeling use cases.
Purpose-built tools, features, and functions make it easy to build, modify, and maintain high-performance models.
Patented Multiverse Modeling™ powers unlimited live scenarios, enabling rapid comparative analysis.
Cloud-enabled Analytical and Presentation modes dynamically animate analysis to broaden projections and enhance decision-making.
Financial Modeling for Pharmaceutical or Bio-Tech Companies
Release the visionary in you with powerful financial modeling intelligence (MI) from Synario. Below find a sample of how our existing clients are using Synario to build the right financial models for their utility.
Custom Drug Lifecycles
Synario can model any drug lifecycle, including custom logic surrounding research and development, clinical trials, market reaction, and patent expiration.
Fully Integrated Financial Statements
Output fully integrated financial statements from your financial models. Synario automatically incorporates changes to your long-term financial projections.
Patient Sales Assumptions
Model sales on a patient basis including market share, price-per-patient, discounts, and more. Easily model over a range of assumptions to see a complete view of your future.
Risk-Adjusted Drug Valuations
Present dynamic risk-adjusted drug or product valuations with Synario. Easily account for potential market changes, clinical trial extensions, or other extenuating scenarios.
Capital Initiative Prioritization
Synario offers toggled capital initiatives in every financial model. See your future with or without a given project or initiative,, all from a single financial model
Equity and Options Structures
Bio-technology companies often have complicated equity structures. The Synario's software can incorporate and project any equity or options structure.
Free of #ref Errors
Integrated Financial Statements
Own Every Meeting with Synario
- Audience-Specific Interfaces – Stakeholders see tailored outputs rather than the entire financial model
- Real-Time Results – New assumptions compute instantly without needing to refresh or save.
- Complete Transparency – Trust your insights with the ability to see how they were calculated.
Build consensus throughout your organization with presentations that evolve with your strategic discussions. When stakeholders are able to actively query your financial models, boardroom questions turn into collaborative conversations.
Financial Model Flexibility without IT Support
IT roadblocks can cause stagnation and frustration throughout a team or department. With Synario, your IT department can safely step aside.
Our patented financial modeling technology works in isolation, meaning your organization does not need to work with IT to connect your existing systems. Furthermore, your organization maintains the flexibility to switch to the latest and greatest technology without reconnecting to Synario.
Your pharmaceutical company does not need to install any new software or connect Synario to your existing ERP/budgeting/accounting platform. Easily upload your financial data and access it anytime via cloud-based web application.
Designed for Collaboration
Synario's financial models are not just meant for modelers. Through the Synario software, CFOs can adjust and modify assumptions and initiatives, quickly creating new views of their organization's future. Meanwhile, stakeholders can view specific presentations composed of accessible insights from financial or strategic model outputs.
Configure, analyze, and understand your financial models from any position.